LENZ Therapeutics Income Statement (2022-2025) | LENZ

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 5.00M12.50M1.59M
Operating items
Research & Development (Quarter) 18.25M17.78M18.30M18.46M10.32M12.64M17.00M10.54M6.95M6.45M5.87M5.82M9.06M3.79M
Selling, General & Administrative (Quarter) 7.71M9.00M7.85M8.29M2.29M2.32M2.86M5.55M7.41M6.49M9.36M11.11M12.80M27.60M0.50M
Other Operating Expenses (Quarter) -0.07M39.55M
Operating Expenses (Quarter) 25.96M26.78M26.15M26.75M12.62M14.96M19.86M16.09M14.35M12.95M15.22M16.93M21.86M31.39M40.05M
Operating Income (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.96M-19.86M-16.09M-14.35M-12.95M-15.22M-16.93M-16.86M-18.89M-38.46M
EBIT (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.96M-19.86M-16.09M-14.35M-12.95M-15.22M-16.93M-16.86M-18.89M-38.46M
Non-operating items
Interest & Investment Income (Quarter) 0.25M1.09M0.79M2.46M2.74M2.57M2.32M2.25M2.20M2.99M
Other Non Operating Income (Quarter) 0.12M0.84M1.47M2.15M-0.05M-0.02M-0.10M-1.35M1.64M-0.01M0.01M-0.01M0.20M-0.01M-0.42M
Non Operating Income (Quarter) 0.12M0.84M2.15M-0.05M0.23M-0.10M-1.35M4.10M2.73M0.01M-0.01M0.20M2.19M-0.42M
Net income details
EBT (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.41M-16.70M-35.89M
Tax Provisions (Quarter) 0.00M0.50M0.00M
Profit After Tax (Quarter) -25.84M-25.94M-24.68M-24.60M-12.67M-14.73M-18.88M-16.65M-10.25M-10.21M-12.65M-14.62M-14.91M-16.70M-35.90M
Income from Continuing Operations (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M
Consolidated Net Income (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M
Income towards Parent Company (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M
Net Income towards Common Stockholders (Quarter) -25.96M-26.78M-26.15M-26.75M-12.62M-14.71M-18.78M-15.30M-10.25M-10.21M-12.65M-14.61M-14.91M-16.70M-35.90M
Additional items
EPS (Basic) (Quarter) -0.48-0.48-0.45-0.44-6.50-7.53-9.62-3.53-0.40-0.38-0.41-0.53-0.53-0.59-1.20
EPS (Weighted Average and Diluted) (Quarter) -0.48-0.48-0.45-0.44-6.50-7.53-9.62-3.53-0.40-0.38-0.41-0.53-0.53-0.59-1.20
Shares Outstanding (Weighted Average) (Quarter) 54.01M54.28M58.09M58.11M55.86M56.75M1.96M4.72M15.16M19.20M21.28M27.53M27.80M28.54M28.81M
Shares Outstanding (Diluted Average) (Quarter) 54.01M54.57M55.21M54.87M1.95M1.95M1.96M4.72M25.61M27.17M21.28M27.53M28.08M28.54M28.81M
EBITDA (Quarter) -25.96M-26.78M-26.15M-26.75M-12.67M-14.74M-18.87M-16.66M-10.31M-9.63M-12.98M-14.69M-15.00M-16.51M-35.88M
Shares Outstanding (Quarter) 58.01M58.21M0.21M1.95M58.19M1.96M57.97M25.50M25.85M27.48M27.52M27.54M28.50M28.59M31.34M
Tax Rate (Quarter) -0.01-3.47-0.01